{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:47:12Z","timestamp":1791478032298,"version":"4.3.4"},"reference-count":107,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81472284"],"award-info":[{"award-number":["81472284"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81372262"],"award-info":[{"award-number":["81372262"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81172020"],"award-info":[{"award-number":["81172020"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Program for Excellent Young Scholars of SMMU"},{"name":"Charitable Project on Cancer Research of Shanghai"},{"name":"State Key Project on Infectious Diseases of China","award":["2012ZX10002-016"],"award-info":[{"award-number":["2012ZX10002-016"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","cancerletters.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.canlet.2015.09.008","type":"journal-article","created":{"date-parts":[[2015,9,26]],"date-time":"2015-09-26T01:32:12Z","timestamp":1443231132000},"page":"198-205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":265,"title":["Intrahepatic cholangiocarcinoma: Epidemiology, risk factors, diagnosis and surgical management"],"prefix":"10.1016","volume":"379","author":[{"given":"Han","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengchao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2015.09.008_bib0010","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1053\/jhep.2001.25087","article-title":"Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States","volume":"33","author":"Patel","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2015.09.008_bib0015","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nrgastro.2011.131","article-title":"Clinical diagnosis and staging of cholangiocarcinoma","volume":"8","author":"Blechacz","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0020","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s00534-002-0732-8","article-title":"Intrahepatic cholangiocarcinoma: macroscopic type and stage classification","volume":"10","author":"Yamasaki","year":"2003","journal-title":"J. Hepatobiliary Pancreat. Surg"},{"key":"10.1016\/j.canlet.2015.09.008_bib0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J. Clin"},{"key":"10.1016\/j.canlet.2015.09.008_bib0030","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jhep.2003.11.030","article-title":"Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?","volume":"40","author":"Shaib","year":"2004","journal-title":"J. Hepatol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0035","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2407-2-10","article-title":"Worldwide trends in mortality from biliary tract malignancies","volume":"2","author":"Patel","year":"2002","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2015.09.008_bib0040","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0168-8278(02)00297-0","article-title":"Changing international trends in mortality rates for liver, biliary and pancreatic tumours","volume":"37","author":"Khan","year":"2002","journal-title":"J. Hepatol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0045","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/13651820801992641","article-title":"Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma","volume":"10","author":"Khan","year":"2008","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.canlet.2015.09.008_bib0050","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jhep.2011.11.015","article-title":"Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?","volume":"56","author":"Khan","year":"2012","journal-title":"J. Hepatol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0055","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bpg.2015.02.001","article-title":"Clinical presentation, risk factors and staging systems of cholangiocarcinoma","volume":"29","author":"Plentz","year":"2015","journal-title":"Best Pract. Res. Clin. Gastroenterol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0060","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.7314\/APJCP.2015.16.9.3931","article-title":"Association between diabetes mellitus and fatty liver based on ultrasonography screening in the world's highest cholangiocarcinoma incidence region, northeast Thailand","volume":"16","author":"Thinkhamrop","year":"2015","journal-title":"Asian Pac. J. Cancer Prev"},{"key":"10.1016\/j.canlet.2015.09.008_bib0065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bpg.2015.02.003","article-title":"Epidemiology of cholangiocarcinoma","volume":"29","author":"Bergquist","year":"2015","journal-title":"Best Pract. Res. Clin. Gastroenterol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0070","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1349-7006.2009.01458.x","article-title":"Epidemiology of cholangiocarcinoma: an update focusing on risk factors","volume":"101","author":"Shin","year":"2010","journal-title":"Cancer Sci"},{"key":"10.1016\/j.canlet.2015.09.008_bib0075","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ejso.2013.12.006","article-title":"Hepatolithiasis-associated cholangiocarcinoma: results from a multi-institutional national database on a case series of 23 patients","volume":"40","author":"Guglielmi","year":"2014","journal-title":"Eur. J. Surg. Oncol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0080","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s00268-014-2476-4","article-title":"Diagnosis and surgical treatment of intrahepatic hepatolithiasis combined with cholangiocarcinoma","volume":"38","author":"Zhu","year":"2014","journal-title":"World J. Surg"},{"key":"10.1016\/j.canlet.2015.09.008_bib0085","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1046\/j.1440-1746.1999.01983.x","article-title":"Peripheral cholangiocarcinoma (cholangiocellular carcinoma): clinical features, diagnosis and treatment","volume":"14","author":"Chen","year":"1999","journal-title":"J. Gastroenterol. Hepatol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0090","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jhep.2008.08.013","article-title":"High lifetime risk of cancer in primary sclerosing cholangitis","volume":"50","author":"Claessen","year":"2009","journal-title":"J. Hepatol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0095","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/MEG.0b013e3283554bbf","article-title":"Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: a 25-year single-centre experience","volume":"24","author":"Chapman","year":"2012","journal-title":"Eur. J. Gastroenterol. Hepatol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2015.05.035","article-title":"Primary sclerosing cholangitis as a pre-malignant biliary tract disease: surveillance and management","author":"Rizvi","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0105","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.24351","article-title":"Risk factors for cholangiocarcinoma","volume":"54","author":"Tyson","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2015.09.008_bib0110","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/003655202760373434","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation","volume":"37","author":"Boberg","year":"2002","journal-title":"Scand. J. Gastroenterol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0115","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/hep.21964","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms","volume":"47","author":"Melum","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2015.09.008_bib0120","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(05)67530-7","article-title":"Cholangiocarcinoma","volume":"366","author":"Khan","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2015.09.008_bib0125","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/00000658-199411000-00007","article-title":"Choledochal cyst disease. A changing pattern of presentation","volume":"220","author":"Lipsett","year":"1994","journal-title":"Ann. Surg"},{"key":"10.1016\/j.canlet.2015.09.008_bib0130","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/jamasurg.2015.0226","article-title":"Presentation and clinical outcomes of choledochal cysts in children and adults: a multi-institutional analysis","volume":"150","author":"Soares","year":"2015","journal-title":"JAMA Surg"},{"key":"10.1016\/j.canlet.2015.09.008_bib0135","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1046\/j.1365-2168.2002.02143.x","article-title":"Liver fluke-associated cholangiocarcinoma","volume":"89","author":"Watanapa","year":"2002","journal-title":"Br. J. Surg"},{"key":"10.1016\/j.canlet.2015.09.008_bib0140","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/jhbp.62","article-title":"Roles of liver fluke infection as risk factor for cholangiocarcinoma","volume":"21","author":"Sithithaworn","year":"2014","journal-title":"J. Hepatobiliary Pancreat. Sci"},{"key":"10.1016\/j.canlet.2015.09.008_bib0145","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00261-001-0148-y","article-title":"Thorotrast-induced cholangiocarcinoma: case report","volume":"28","author":"Sahani","year":"2003","journal-title":"Abdom. Imaging"},{"key":"10.1016\/j.canlet.2015.09.008_bib0150","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/jhbp.137","article-title":"Characteristics of printing company workers newly diagnosed with occupational cholangiocarcinoma","volume":"21","author":"Kubo","year":"2014","journal-title":"J. Hepatobiliary Pancreat. Sci"},{"key":"10.1016\/j.canlet.2015.09.008_bib0155","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1002\/1097-0142(20000601)88:11<2471::AID-CNCR7>3.0.CO;2-T","article-title":"Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis","volume":"88","author":"Kobayashi","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2015.09.008_bib0160","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.cgh.2007.05.020","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study","volume":"5","author":"Welzel","year":"2007","journal-title":"Clin. Gastroenterol. Hepatol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0165","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1023\/A:1013747228572","article-title":"Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy","volume":"12","author":"Donato","year":"2001","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.canlet.2015.09.008_bib0170","first-page":"1369","article-title":"[A case of minute cholangiocellular carcinoma which was found in the follow-up periods of liver cirrhosis and was indistinguishable from hepatocellular carcinoma on hepatic angiography]","volume":"88","author":"Nagaoka","year":"1991","journal-title":"Nihon Shokakibyo Gakkai Zasshi"},{"key":"10.1016\/j.canlet.2015.09.008_bib0175","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12957-015-0583-9","article-title":"Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies","volume":"13","author":"Li","year":"2015","journal-title":"World J. Surg. Oncol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0180","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1038\/sj.bjc.6605063","article-title":"Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma","volume":"100","author":"Lee","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2015.09.008_bib0185","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1245\/s10434-010-1458-5","article-title":"Evaluation of risk factors and clinicopathologic features for intrahepatic cholangiocarcinoma in Southern China: a possible role of hepatitis B virus","volume":"18","author":"Peng","year":"2011","journal-title":"Ann. Surg. Oncol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0190","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrgastro.2013.183","article-title":"NAFLD, NASH and liver cancer","volume":"10","author":"Michelotti","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0195","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1053\/j.gastro.2004.12.048","article-title":"Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study","volume":"128","author":"Shaib","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2015.09.008_bib0200","doi-asserted-by":"crossref","first-page":"8780","DOI":"10.3748\/wjg.v19.i46.8780","article-title":"Smoking, alcohol consumption, and the risk of extrahepatic cholangiocarcinoma: a meta-analysis","volume":"19","author":"Ye","year":"2013","journal-title":"World J. Gastroenterol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0205","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2012.02.022","article-title":"Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma","volume":"57","author":"Palmer","year":"2012","journal-title":"J. Hepatol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0210","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/hep.24397","article-title":"Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database","volume":"54","author":"Welzel","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2015.09.008_bib0215","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/j.1572-0241.2007.01104.x","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study","volume":"102","author":"Shaib","year":"2007","journal-title":"Am. J. Gastroenterol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0220","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.soc.2013.10.004","article-title":"Intrahepatic cholangiocarcinoma","volume":"23","author":"Brown","year":"2014","journal-title":"Surg. Oncol. Clin. N. Am"},{"key":"10.1016\/j.canlet.2015.09.008_bib0225","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/j.1365-2133.2006.07521.x","article-title":"Sweet syndrome associated with intrahepatic cholangiocarcinoma producing granulocyte colony-stimulating factor","volume":"155","author":"Shinojima","year":"2006","journal-title":"Br. J. Dermatol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0230","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1046\/j.1365-2133.2001.04393.x","article-title":"Oral acanthosis nigricans, the sign of Leser-Trelat and cholangiocarcinoma","volume":"145","author":"Scully","year":"2001","journal-title":"Br. J. Dermatol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0235","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00000658-199610000-00005","article-title":"Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors","volume":"224","author":"Nakeeb","year":"1996","journal-title":"Ann. Surg"},{"key":"10.1016\/j.canlet.2015.09.008_bib0240","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hep.510310103","article-title":"Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study","volume":"31","author":"Chalasani","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2015.09.008_bib0245","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1572-0241.2000.01685.x","article-title":"The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis","volume":"95","author":"Patel","year":"2000","journal-title":"Am. J. Gastroenterol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0250","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1245\/s10434-008-0081-1","article-title":"Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma","volume":"15","author":"Tamandl","year":"2008","journal-title":"Ann. Surg. Oncol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0255","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1002\/cncr.28312","article-title":"Multidisciplinary approaches to intrahepatic cholangiocarcinoma","volume":"119","author":"Maithel","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2015.09.008_bib0260","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s002610000079","article-title":"Intrahepatic peripheral cholangiocarcinoma: CT evaluation","volume":"25","author":"Valls","year":"2000","journal-title":"Abdom. Imaging"},{"key":"10.1016\/j.canlet.2015.09.008_bib0265","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1148\/radiol.11101777","article-title":"Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern \u2013 correlation with clinicopathologic findings","volume":"260","author":"Kim","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.canlet.2015.09.008_bib0270","first-page":"2786","article-title":"Enhancement patterns of intrahepatic mass-forming cholangiocarcinoma at multiphasic computed tomography and magnetic resonance imaging and correlation with clinicopathologic features","volume":"19","author":"Ciresa","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci"},{"key":"10.1016\/j.canlet.2015.09.008_bib0275","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bpg.2015.02.004","article-title":"Radiological diagnosis in cholangiocarcinoma: Application of computed tomography, magnetic resonance imaging, and positron emission tomography","volume":"29","author":"Ringe","year":"2015","journal-title":"Best Pract. Res. Clin. Gastroenterol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0280","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann. Surg. Oncol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0285","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/hpb.12333","article-title":"Model to predict survival after surgical resection of intrahepatic cholangiocarcinoma: the Mayo Clinic experience","volume":"17","author":"Ali","year":"2015","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.canlet.2015.09.008_bib0290","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/hpb.12441","article-title":"Intrahepatic cholangiocarcinoma: expert consensus statement","volume":"17","author":"Weber","year":"2015","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.canlet.2015.09.008_bib0295","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/13651820801992690","article-title":"Staging laparoscopy for cholangiocarcinoma","volume":"10","author":"Joseph","year":"2008","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.canlet.2015.09.008_bib0300","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00464-005-0583-x","article-title":"Utility of staging laparoscopy in subsets of biliary cancers: laparoscopy is a powerful diagnostic tool in patients with intrahepatic and gallbladder carcinoma","volume":"20","author":"Goere","year":"2006","journal-title":"Surg. Endosc"},{"key":"10.1016\/j.canlet.2015.09.008_bib0305","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/01.sla.0000201482.11876.14","article-title":"Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up","volume":"243","author":"Nagino","year":"2006","journal-title":"Ann. Surg"},{"key":"10.1016\/j.canlet.2015.09.008_bib0310","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/01.SLA.0000065265.16728.C0","article-title":"Preoperative portal vein embolization for extended hepatectomy","volume":"237","author":"Hemming","year":"2003","journal-title":"Ann. Surg"},{"key":"10.1016\/j.canlet.2015.09.008_bib0315","first-page":"22","article-title":"Risk factors for early bilirubinemia after major hepatectomy for perihilar cholangiocarcinoma with portal vein embolization","volume":"57","author":"Sakamoto","year":"2010","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.canlet.2015.09.008_bib0320","first-page":"1341","article-title":"Preoperative portal vein embolization for hilar cholangiocarcinoma \u2013 a comparative study","volume":"57","author":"Yi","year":"2010","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.canlet.2015.09.008_bib0325","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jamcollsurg.2013.05.021","article-title":"Intrahepatic cholangiocarcinoma: management options and emerging therapies","volume":"217","author":"Dodson","year":"2013","journal-title":"J. Am. Coll. Surg"},{"key":"10.1016\/j.canlet.2015.09.008_bib0330","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.29619","article-title":"Can hepatic resection provide a long-term cure for patients with intrahepatic cholangiocarcinoma?","author":"Spolverato","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2015.09.008_bib0335","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1245\/s10434-007-9627-x","article-title":"Surgical management of intrahepatic cholangiocarcinoma \u2013 a population-based study","volume":"15","author":"Tan","year":"2008","journal-title":"Ann. Surg. Oncol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0340","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.ejso.2015.05.013","article-title":"Intrahepatic, peri-hilar and distal cholangiocarcinoma: three different locations of the same tumor or three different tumors?","volume":"41","author":"Ercolani","year":"2015","journal-title":"Eur. J. Surg. Oncol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0345","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1200\/JCO.2011.35.6519","article-title":"Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment","volume":"29","author":"de Jong","year":"2011","journal-title":"J. Clin. Oncol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0350","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/SLA.0b013e318176c4d3","article-title":"Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection","volume":"248","author":"Endo","year":"2008","journal-title":"Ann. Surg"},{"key":"10.1016\/j.canlet.2015.09.008_bib0355","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.surg.2014.11.011","article-title":"Extended liver resections for intrahepatic cholangiocarcinoma: friend or foe?","volume":"157","author":"Bergeat","year":"2015","journal-title":"Surgery"},{"key":"10.1016\/j.canlet.2015.09.008_bib0360","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/archsurg.2012.1962","article-title":"surgical approach for long-term survival of patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis of 434 patients","volume":"147","author":"Ribero","year":"2012","journal-title":"Arch. Surg"},{"key":"10.1016\/j.canlet.2015.09.008_bib0365","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.soc.2008.12.010","article-title":"Management and extent of resection for intrahepatic cholangiocarcinoma","volume":"18","author":"Carpizo","year":"2009","journal-title":"Surg. Oncol. Clin. N. Am"},{"key":"10.1016\/j.canlet.2015.09.008_bib0370","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1002\/cncr.25712","article-title":"AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: by the AFC-IHCC-2009 study group","volume":"117","author":"Farges","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2015.09.008_bib0375","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s005340050093","article-title":"Extended resection for intrahepatic cholangiocarcinoma in Japan","volume":"6","author":"Yamamoto","year":"1999","journal-title":"J. Hepatobiliary Pancreat. Surg"},{"key":"10.1016\/j.canlet.2015.09.008_bib0380","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1002\/cncr.29419","article-title":"Impact of complications on long-term survival after resection of intrahepatic cholangiocarcinoma","volume":"121","author":"Spolverato","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2015.09.008_bib0385","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.amjsurg.2004.11.009","article-title":"Treatment and outcome of intrahepatic cholangiocellular carcinoma","volume":"189","author":"Puhalla","year":"2005","journal-title":"Am. J. Surg"},{"key":"10.1016\/j.canlet.2015.09.008_bib0390","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1440-1746.2007.05040.x","article-title":"What prognostic factors are important for resected intrahepatic cholangiocarcinoma?","volume":"23","author":"Paik","year":"2008","journal-title":"J. Gastroenterol. Hepatol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0395","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jamasurg.2013.5137","article-title":"Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis","volume":"149","author":"Mavros","year":"2014","journal-title":"JAMA Surg"},{"key":"10.1016\/j.canlet.2015.09.008_bib0400","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S1072-7515(01)01016-X","article-title":"Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes","volume":"193","author":"Weber","year":"2001","journal-title":"J. Am. Coll. Surg"},{"key":"10.1016\/j.canlet.2015.09.008_bib0405","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-015-4472-9","article-title":"The impact of surgical margin status on long-term outcome after resection for intrahepatic cholangiocarcinoma","author":"Spolverato","year":"2015","journal-title":"Ann. Surg. Oncol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0410","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1007\/s00268-007-9001-y","article-title":"Surgical resection of hilar cholangiocarcinoma: analysis of survival and postoperative complications","volume":"31","author":"Hasegawa","year":"2007","journal-title":"World J. Surg"},{"key":"10.1016\/j.canlet.2015.09.008_bib0415","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1634\/theoncologist.2012-0432","article-title":"Adjuvant therapy for intrahepatic cholangiocarcinoma: the debate continues","volume":"17","author":"Zhu","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.canlet.2015.09.008_bib0420","article-title":"Management and outcomes of patients with recurrent intrahepatic cholangiocarcinoma following previous curative-intent surgical resection","author":"Spolverato","year":"2015","journal-title":"Ann. Surg. Oncol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0425","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","article-title":"Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma","volume":"60","author":"Bridgewater","year":"2014","journal-title":"J. Hepatol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0430","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000332827","article-title":"The role of liver transplantation for intrahepatic cholangiocarcinoma: a single-center experience","volume":"47","author":"Fu","year":"2011","journal-title":"Eur. Surg. Res"},{"key":"10.1016\/j.canlet.2015.09.008_bib0435","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1016\/j.transproceed.2008.08.053","article-title":"Liver transplantation as a primary indication for intrahepatic cholangiocarcinoma: a single-center experience","volume":"40","author":"Sotiropoulos","year":"2008","journal-title":"Transplant. Proc"},{"key":"10.1016\/j.canlet.2015.09.008_bib0440","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/archsurg.2011.116","article-title":"Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single center","volume":"146","author":"Hong","year":"2011","journal-title":"Arch. Surg"},{"key":"10.1016\/j.canlet.2015.09.008_bib0445","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/ajt.12591","article-title":"\u201cVery early\u201d intrahepatic cholangiocarcinoma in cirrhotic patients: should liver transplantation be reconsidered in these patients?","volume":"14","author":"Sapisochin","year":"2014","journal-title":"Am. J. Transplant"},{"key":"10.1016\/j.canlet.2015.09.008_bib0450","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/SLA.0000000000000494","article-title":"Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation: a Spanish matched cohort multicenter study","volume":"259","author":"Sapisochin","year":"2014","journal-title":"Ann. Surg"},{"key":"10.1016\/j.canlet.2015.09.008_bib0455","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/jso.23781","article-title":"Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma","volume":"111","author":"Boehm","year":"2015","journal-title":"J. Surg. Oncol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0460","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/1097-0142(19870915)60:6<1194::AID-CNCR2820600607>3.0.CO;2-T","article-title":"A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge","volume":"60","author":"Sasaki","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2015.09.008_bib0465","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ejso.2013.03.010","article-title":"Comparison of resection and transarterial chemoembolisation in the treatment of advanced intrahepatic cholangiocarcinoma \u2013 a single-center experience","volume":"39","author":"Scheuermann","year":"2013","journal-title":"Eur. J. Surg. Oncol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0470","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ejso.2012.02.185","article-title":"Postoperative adjuvant transcatheter arterial chemoembolisation improves survival of intrahepatic cholangiocarcinoma patients with poor prognostic factors: results of a large monocentric series","volume":"38","author":"Wu","year":"2012","journal-title":"Eur. J. Surg. Oncol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0475","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.crad.2010.11.002","article-title":"Transarterial chemoembolization versus supportive therapy in the palliative treatment of unresectable intrahepatic cholangiocarcinoma","volume":"66","author":"Park","year":"2011","journal-title":"Clin. Radiol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0480","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00270-009-9694-4","article-title":"OEM-TACE: a new therapeutic approach in unresectable intrahepatic cholangiocarcinoma","volume":"32","author":"Poggi","year":"2009","journal-title":"Cardiovasc. Intervent. Radiol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0485","first-page":"437","article-title":"Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and systemic chemotherapy","volume":"24","author":"Kuhlmann","year":"2012","journal-title":"Eur. J. Gastroenterol. Hepatol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0490","doi-asserted-by":"crossref","first-page":"W205","DOI":"10.2214\/AJR.10.4937","article-title":"Radiofrequency ablation for the treatment of primary intrahepatic cholangiocarcinoma","volume":"196","author":"Kim","year":"2011","journal-title":"Am. J. Roentgenol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0495","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jvir.2015.02.024","article-title":"Radiofrequency ablation in the treatment of unresectable intrahepatic cholangiocarcinoma: systematic review and meta-analysis","volume":"26","author":"Han","year":"2015","journal-title":"J. Vasc. Interv. Radiol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0500","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/cncr.10831","article-title":"Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma","volume":"95","author":"Takada","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2015.09.008_bib0505","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jama.2012.7352","article-title":"Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial","volume":"308","author":"Neoptolemos","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.canlet.2015.09.008_bib0510","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.canlet.2015.09.008_bib0515","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1517\/14728214.2014.870553","article-title":"Emerging drugs for biliary cancer","volume":"19","author":"Okusaka","year":"2014","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.canlet.2015.09.008_bib0520","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1634\/theoncologist.2007-0252","article-title":"Systemic therapy for biliary tract cancers","volume":"13","author":"Hezel","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.canlet.2015.09.008_bib0525","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1200\/JCO.2009.27.4787","article-title":"Genetics of biliary tract cancers and emerging targeted therapies","volume":"28","author":"Hezel","year":"2010","journal-title":"J. Clin. Oncol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0530","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1245\/s10434-014-3828-x","article-title":"Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets","volume":"21","author":"Zhu","year":"2014","journal-title":"Ann. Surg. Oncol"},{"key":"10.1016\/j.canlet.2015.09.008_bib0535","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/hep.24145","article-title":"Development of molecularly targeted therapies in biliary tract cancers: reassessing the challenges and opportunities","volume":"53","author":"Zhu","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2015.09.008_bib0540","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1470-2045(11)70301-1","article-title":"Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study","volume":"13","author":"Lee","year":"2012","journal-title":"Lancet Oncol"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383515005881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383515005881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T01:51:25Z","timestamp":1537321885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383515005881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":107,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0304383515005881"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2015.09.008","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intrahepatic cholangiocarcinoma: Epidemiology, risk factors, diagnosis and surgical management","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2015.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}